Juan F Gallegos-Orozco
Overview
Explore the profile of Juan F Gallegos-Orozco including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
772
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jensen M, Jensen M, Gallegos-Orozco J
Liver Transpl
. 2025 Jan;
PMID: 39868932
No abstract available.
2.
Izzy M, Fortune B, Serper M, Bhave N, deLemos A, Gallegos-Orozco J, et al.
Am J Transplant
. 2022 Mar;
22(12):2740-2758.
PMID: 35359027
Cardiac diseases are one of the most common causes of morbidity and mortality following liver transplantation (LT). Prior studies have shown that cardiac diseases affect close to one-third of liver...
3.
Chandna S, Zarate E, Gallegos-Orozco J
Surg Clin North Am
. 2021 Nov;
102(1):117-137.
PMID: 34800381
Patients with cirrhosis account for 3% of intensive care unit admissions with hospital mortality exceeding 50%; however, improvements in survival among patients with acutely decompensated cirrhosis and organ failure have...
4.
Gallegos-Orozco J
Am J Gastroenterol
. 2019 Oct;
114(11):1712-1713.
PMID: 31658103
Through detailed analyses of the National Health and Nutrition Examination Survey, the Nationwide Inpatient Sample, and the United Network for Organ Sharing registry, the authors provide a view of the...
5.
Garcia-Tsao G, Fuchs M, Shiffman M, Borg B, Pyrsopoulos N, Shetty K, et al.
Hepatology
. 2018 Aug;
69(2):717-728.
PMID: 30063802
Caspases play a central role in apoptosis, inflammation, and fibrosis. They produce hemodynamically active, proinflammatory microparticles that cause intrahepatic inflammation, vasoconstriction, and extrahepatic splanchnic vasodilation. Emricasan is a pan-caspase inhibitor...
6.
Mucocele mimicking a gallbladder in a transplanted liver: A case report and review of the literature
Chaly T, Campsen J, OHara R, Hardman R, Gallegos-Orozco J, Thiesset H, et al.
World J Transplant
. 2018 Jan;
7(6):359-363.
PMID: 29312865
Biliary mucoceles after deceased donor liver transplantation are a rarity, and mucoceles mimicking a gallbladder from the recipient remnant cystic duct have not been described until this case. We describe...
7.
Gallegos-Orozco J, Charlton M
Clin Liver Dis
. 2017 Apr;
21(2):367-379.
PMID: 28364819
Indications for liver transplant have been extended, and older and sicker patients are undergoing transplantation. Infectious, malignant, and cardiovascular diseases account for the most posttransplant deaths. Cirrhotic patients can develop...
8.
Gallegos-Orozco J, Kim R, Thiesset H, Hatch J, Lynch K, Chaly Jr T, et al.
Cureus
. 2016 Dec;
8(11):e890.
PMID: 28018760
Introduction: Hepatitis C virus (HCV) infection in kidney transplant (KTX) patients reduces long-term patient and graft survival. Direct-acting antivirals (DAA) are > 90% effective in achieving sustained viral response (SVR);...
9.
Samadder N, Smith K, Wong J, Hanson H, Boucher K, Burt R, et al.
Dig Dis Sci
. 2016 Sep;
61(12):3627-3632.
PMID: 27655103
Background And Objectives: Biliary tract cancers (BTC) including, cholangiocarcinoma (CC) and gallbladder cancer (GBC), are rare and highly fatal malignancies. The etiology and inherited susceptibility of both malignancies are poorly...
10.
Gallegos-Orozco J, Charlton M
Clin Liver Dis
. 2016 Jul;
20(3):521-34.
PMID: 27373614
Excessive alcohol use is a common health care problem worldwide and is associated with significant morbidity and mortality. Alcoholic liver disease represents the second most frequent indication for liver transplantation...